carmustine
Drug Details
- Generic Name
- carmustine
- Brand Names
- Gliadel, carmustine, Carmustine
- Application Number
- NDA020637
- Sponsor
- Azurity Pharmaceuticals, Inc.
- NDC Codes
- 7
- Dosage Forms
- WAFER, KIT
- Routes
- INTRACAVITARY, INTRAVENOUS
- Active Ingredients
- CARMUSTINE
Indications and Usage
1 INDICATIONS AND USAGE Carmustine for injection is indicated as palliative therapy as a single agent or in established combination therapy in the following: - Brain tumors glioblastoma, brainstem glioma, medulloblastoma, astrocytoma, ependymoma, and metastatic brain tumors. - Multiple myeloma in combination with prednisone. - Relapsed or refractory Hodgkin's lymphoma in combination with other approved drugs. - Relapsed or refractory Non-Hodgkin's lymphomas in combination with other approved drugs. Carmustine for injection is a nitrosourea indicated as palliative therapy as a single agent or in established combination therapy with other approved chemotherapeutic agents in the following: Brain tumors glioblastoma, brainstem glioma, medulloblastoma, astrocytoma, ependymoma, and metastatic brain tumors. ( 1 ) Multiple myeloma-in combination with prednisone. ( 1 ) Relapsed or refractory Hodgkin's lymphoma in combination with other approved drugs. ( 1 ) Relapsed or refractory Non-Hodgkin's lymphomas in combination with other approved drugs. ( 1 )